Geron Corp (Menlo Park, CA) announced the issuance of two patents by the UK Patent Office covering the nuclear transfer technology used to produce Dolly the sheep, the first animal cloned from an ...

In a report released today, Peter Lawson from Barclays maintained a Buy rating on Geron (GERN – Research Report), with a price target of $9.00. The company’s shares closed yesterday at $2.94.

FOSTER CITY, Calif.--(BUSINESS WIRE)--Geron Corporation (Nasdaq: GERN), a commercial-stage biopharmaceutical company aiming to change lives by changing the course of blood cancer, today announced ...